Overview

Bioavailability of Trazodone Hydrochloride (New Polymer) vs. Trazodone Hydrochloride Contramid at Steady-state.

Status:
COMPLETED
Trial end date:
2024-08-07
Target enrollment:
Participant gender:
Summary
Two way, two parallel groups, crossover study to compare the bioavailability of 150 mg and 300 mg trazodone hydrochloride (new polymer) (Angelini Pharma S.p.A.) vs. 150 mg and 300 mg trazodone hydrochloride Contramid (Angelini Pharma S.p.A.) at steady-state in 64 Healthy Volunteers.
Phase:
PHASE1
Details
Lead Sponsor:
Aziende Chimiche Riunite Angelini Francesco S.p.A
Collaborator:
SocraTec R&D GmbH
Treatments:
Trazodone